CRESTOR is indicated for patients with primary hypercholesterolaemia, (type IIa, including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and exercise is inadequate.
CRESTOR reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol.
CRESTOR is also indicated in patients with homozygous familial hypercholesterolemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL aphaeresis).
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                        
                
                                    
                                            
 Sign Out